Harlem Biospace Fellows

Harlem Biospace Fellows are consultants to the community of companies here at Hb and contribute to both the technical design of products and the creation of business strategy. The current group ranges from biotechnology undergraduate students eager to carry out routine work to experienced healthcare consultants and postdoctoral researchers who can bring valuable perspective to the table. In return, Fellows are given access to training events and gain operational experience useful to finding a full-time opportunity in early stage biotech.


To become a Fellow, please email director@harlembiospace.com and we will get back to you with any available opportunities.


The current cohort of Hb Fellows includes:


Shantenu Agarwal

Shantenu has been growing ideas into products and companies for the past decade. A bioengineer by training, Shantenu has co-founded two health tech startups, worked at a healthcare focused venture capital fund, and managed corporate business development for a large Fortune 500 company across the world. His role as a Product Manager in an Artificial Intelligence company coupled with his experience in innovating and building allows him to assist inventors/co-founders think strategically through ideas, markets, and scale.

Yinka Akinyemi 300x300.jpg

Yinka Akinyemi

Yinka is a Vice President in Healthcare Investment Banking at Loop Capital Markets.  He focuses on advisory, licensing and capital raising for life science companies, and has both buy-side and sell-side deal experiences in licensing, cross border M&A, private capital raises (for clinical stage life science companies), and debt/equity capital markets issuance (for large cap companies). He previously worked in Citigroup’s Global Healthcare Group and in Investment Banking at Santander. Yinka received his M.B.A. from Duke University’s Fuqua School of Business, and B.B.A. from the University of Georgia.

Morgan Kiss_2016.jpg

Morgan Kiss

Morgan is a member of the Corporate Development team at Axel Johnson, a private investment firm with holdings in the medical technology industry, among others. She is involved in sourcing investment opportunities, executing deal processes and managing strategic and operational projects to promote growth of companies in the portfolio. She is passionate about supporting the development of the life sciences sector and works closely with HighRes Biosolutions, a designer and manufacturer of laboratory automation systems used in drug discovery efforts. Morgan holds a B.S. in Biomedical Engineering from Yale University. 

Andre Mota Image.jpg

André Mota

André is a health policy and strategy consultant at Manatt Health Strategies, where he focuses on life sciences companies, provider organizations, and digital health capabilities. He is passionate about advancing New York City's biotechnology and digital health ecosystems. André has worked across several health care functions, including government affairs and policy at Pfizer, biotechnology equity research at T. Rowe Price, business development at Novartis, and technology transfer and commercialization at Johns Hopkins University. He received a B.S. in Biology with minors in Global Health and Business from UC San Diego, and a M.S.P.H. in Health Policy from the Johns Hopkins Bloomberg School of Public Health.

Chirag Raval.jpg

Chirag Raval, PH.D.

Chirag is a passionate problem solver and start-up co-founder focused on extending human longevity by harnessing nature at the nanoscale. He serves as an educator at the City University of New York and leverages his extensive experience in chemical and biomolecular engineering to cultivate the NYC life science ecosystem as a research scholar and public health advocate. Chirag applies his experience in design, regulatory strategy and commercial development of biomedical enterprises with Hb member companies.


Catherine Tang

Catherine is an associate at PJT Partners, where she focuses on financial and strategic advisory for life sciences companies. She has experience in acquisitions, divestitures, contingent value rights, licensing, company valuations, and evaluation of strategic alternatives in development and commercial stage biopharmaceutical, medtech, and healthcare IT companies. Previously, she held undergraduate research roles in genetics and biochemistry labs. Catherine received a B.A. in Biochemistry and a B.S. in Economics with a concentration in Finance from the University of Pennsylvania.


Lona Vincent

Lona is currently working in strategy and design thinking at Johnson & Johnson in New York City where she supports the healthcare, pharmaceutical, and medical device businesses. A former management consultant and researcher, Lona seeks to bring her background in strategy, operations, business development, partnerships, business modeling, human centered design, and product development to the growing New York startup sector. She has a Masters in Public Health from Columbia University in New York.

Sarah Weber

Sarah is currently an equity research analyst at Piper Jaffray, where she focuses on the Emerging Biopharma sector. She is passionate about contributing to the growing biotech sector right here in NYC and began volunteering at Harlem Biospace in 2015. Her past experience includes marketing consulting at an NYC startup as well as clinical research in Crohn’s Disease at Boston Children’s Hospital. Sarah graduated from Williams College in 2011 with a B.A. in psychology and neuroscience.